| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Division of Rheumatology, Children’s Hospital Medical Center, and
Division of Comparative Pathology, University of Cincinnati, Cincinnati, OH 45229; and
Department of Medicine and
§
Ben May Institute for Cancer Research, University of Chicago, Chicago, IL 60637
Autoimmune arthritides are characterized by an imbalance between pro- and anti-inflammatory cytokines. Viral IL-10 (vIL-10) shares many of the anti-inflammatory properties of mouse and human IL-10, but lacks their immunostimulatory properties and may therefore offer superior immunosuppression. Viral IL-10 has a short half-life; however, genetic modification of cells in vivo offers a potential means of achieving prolonged therapeutic titers. To determine the effects on collagen-induced arthritis of vIL-10 gene transfer, DBA/1 mice were administered i.v. or intra-articular injections of Av(vIL-10), a replication-deficient adenovirus encoding vIL-10. The i.v. injection of Av(vIL-10) before disease onset delayed the onset and reduced the severity of collagen-induced arthritis, but treatment of established disease was ineffective. The preventative effects were not due to decreased anti-type II collagen Ab production. Rather, T cells from mice treated with Av(vIL-10) demonstrated a decreased in vitro proliferative response to type II collagen, and a delay was observed in up-regulation of synovial mRNA for the proinflammatory cytokines IL-2 and IL-1ß. Intra-articular injection of Av(vIL-10) into knee joints did not reduce arthritis in the knees, but inhibited the development of arthritis in the paws. Humoral and cellular immune responses against Av(vIL-10) were observed. These results demonstrate that vIL-10 can significantly alter the course of autoimmune arthritis and emphasize the complexities of using gene transfer as a method of drug delivery for arthritis.
This article has been cited by other articles:
|
|
 |
|
  B. Slobedman, P. A. Barry, J. V. Spencer, S. Avdic, and A. Abendroth Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function J. Virol., October 1, 2009; 83(19): 9618 - 9629. [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Brown, A. Y.-C. Lai, S. T. Callen, V. A. Blaho, J. M. Hughes, and W. J. Mitchell Adenoviral Delivery of Interleukin-10 Fails To Attenuate Experimental Lyme Disease Infect. Immun., December 1, 2008; 76(12): 5500 - 5507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lucas and G. McFadden Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics J. Immunol., October 15, 2004; 173(8): 4765 - 4774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhu, D. Stevenson, J. E. Schechter, A. K. Mircheff, T. Ritter, L. Labree, and M. D. Trousdale Prophylactic Effect of IL-10 Gene Transfer on Induced Autoimmune Dacryoadenitis Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1375 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inoue, T. Otsuka, H. Niiro, S. Nagano, Y. Arinobu, E. Ogami, M. Akahoshi, K. Miyake, I. Ninomiya, S. Shimizu, et al. Novel Regulatory Mechanisms of CD40-Induced Prostanoid Synthesis by IL-4 and IL-10 in Human Monocytes J. Immunol., February 15, 2004; 172(4): 2147 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zuo, C. M. Cullen, M. L. DeLay, S. Thornton, L. K. Myers, E. F. Rosloniec, G. P. Boivin, and R. Hirsch A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness J. Immunol., March 1, 2002; 168(5): 2554 - 2559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Kaya, K. M. Dohmen, Y. Wang, J. Schlichting, M. Afanasyeva, F. Leuschner, and N. R. Rose Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis J. Immunol., February 15, 2002; 168(4): 1552 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Childs, J. J. Goater, R. J. O'Keefe, and E. M. Schwarz Effect of Anti-Tumor Necrosis Factor-{alpha} Gene Therapy on Wear Debris-Induced Osteolysis J. Bone Joint Surg. Am., December 1, 2001; 83(12): 1789 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. M. Johansson, A.-S. Hansson, K. S. Nandakumar, J. Backlund, and R. Holmdahl IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies J. Immunol., September 15, 2001; 167(6): 3505 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Quattrocchi, M. J. Dallman, A. P. Dhillon, A. Quaglia, G. Bagnato, and M. Feldmann Murine IL-10 Gene Transfer Inhibits Established Collagen-Induced Arthritis and Reduces Adenovirus-Mediated Inflammatory Responses in Mouse Liver J. Immunol., May 15, 2001; 166(10): 5970 - 5978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Croxford, M. Feldmann, Y. Chernajovsky, and D. Baker Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System J. Immunol., March 15, 2001; 166(6): 4124 - 4130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Fort, R. Lesley, N. J. Davidson, S. Menon, F. Brombacher, M. W. Leach, and D. M. Rennick IL-4 Exacerbates Disease in a Th1 Cell Transfer Model of Colitis J. Immunol., February 15, 2001; 166(4): 2793 - 2800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Setoguchi, Y. Misaki, Y. Araki, K. Fujio, K. Kawahata, T. Kitamura, and K. Yamamoto Antigen-Specific T Cells Transduced with IL-10 Ameliorate Experimentally Induced Arthritis Without Impairing the Systemic Immune Response to the Antigen J. Immunol., November 15, 2000; 165(10): 5980 - 5986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Legge, B. Min, J. J. Bell, J. C. Caprio, L. Li, R. K. Gregg, and H. Zaghouani Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Myelin-Activated T Cells and Ameliorates Experimental Allergic Encephalomyelitis J. Exp. Med., June 19, 2000; 191(12): 2039 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Henke, L. A. DeBrunye, R. M. Strieter, J. S. Bromberg, M. Prince, A. M. Kadell, M. Sarkar, F. Londy, and T. W. Wakefield Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis J. Immunol., February 15, 2000; 164(4): 2131 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-N. Kim, S. Watanabe, Y. Ma, S. Thornton, E. H. Giannini, and R. Hirsch Viral IL-10 and Soluble TNF Receptor Act Synergistically to Inhibit Collagen-Induced Arthritis Following Adenovirus- Mediated Gene Transfer J. Immunol., February 1, 2000; 164(3): 1576 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Brown, J. F. Zachary, C. Teuscher, J. J. Weis, and R. M. Wooten Dual Role of Interleukin-10 in Murine Lyme Disease: Regulation of Arthritis Severity and Host Defense Infect. Immun., October 1, 1999; 67(10): 5142 - 5150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Lechman, D. Jaffurs, S. C. Ghivizzani, A. Gambotto, I. Kovesdi, Z. Mi, C. H. Evans, and P. D. Robbins Direct Adenoviral Gene Transfer of Viral IL-10 to Rabbit Knees with Experimental Arthritis Ameliorates Disease in Both Injected and Contralateral Control Knees J. Immunol., August 15, 1999; 163(4): 2202 - 2208. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
